Quantcast
Last updated on April 16, 2014 at 8:56 EDT

Latest Statistical inference Stories

2009-05-26 07:30:00

HENDERSON, Nev., May 26 /PRNewswire-FirstCall/ -- Ireland Inc. (OTC Bulletin Board: IRLD) ("Ireland") ("the Company"), a minerals exploration and development company focused on the discovery and extraction of precious metals from mineral deposits in the Southwestern United States, today announced that it has completed leach tests on composite drill samples taken from Zone B of the Company's Columbus Project located in Esmeralda County, Nevada. The results of these bench scale (5.5 lbs) leach...

2009-05-11 07:15:00

ST. PETERSBURG, Fla., May 11 /PRNewswire-FirstCall/ -- EClips Energy Technologies, Inc., (OTC Bulletin Board: ECET) announced today the initiation of a final series of tests for its PATI (Pure Air Technology) system prototype developed by EET over the past two years. The Company anticipates that these tests will prove that the PATI system produces 'sterile' air, devoid of any biological or chemical contaminants. This technology would meet the fast-growing demand for improved air quality...

2009-05-05 15:56:00

Revenues Grow 131% and Expenses Reduced by 36% over Q1 2008 VANCOUVER, May 5 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) reported that it recorded total revenues of $2,712,401 and a net loss of $1,731,415 or ($0.01) per share for the three month period ended March 31, 2009. First quarter total revenues, higher than preliminary estimates, increased 131% to $2,712,401 compared to $1,173,121 for the same period in 2008. This represents the highest revenues...

2009-05-04 07:00:00

ST. PETERSBURG, Fla., May 4 /PRNewswire-FirstCall/ -- EClips Energy Technologies, Inc., (OTC Bulletin Board: ECET) today reported that it has successfully completed a first series of tests of its Pure Air System (PATI) in passenger coaches owned by a local transport company. The Company will be conducting additional tests in coming weeks through an arrangement with a national transport company. The test results showed that after several hours of treatment, all biological and chemical...

2009-04-20 07:00:00

Revenues Grow 115% Over Q1 2008 VANCOUVER, April 20 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) today announced preliminary unaudited revenues for the three-month period ended March 31, 2009. First quarter revenues increased 115% to approximately $2.526 million compared to $1.173 million for the same period in 2008. This represents the highest revenues for any quarter in the Company's history and, as expected, includes a significant contribution by the...

2009-04-07 06:45:00

PASADENA, Calif., April 7 /PRNewswire-FirstCall/ -- Jacobs Engineering Group Inc. (NYSE: JEC) announced today that it was awarded the first of two one-year options for test and evaluation support at NASA's White Sands Test Facility near Las Cruces, N.M., after successfully completing a three-year base period. The option year has a potential value of $54 million. The contract, which began May 2006, has a potential total value of $270.5 million if all options are exercised. Jacobs will...

2009-03-25 09:00:00

Strengthens the Firm's Preconstruction Services IRVINE, Calif., March 25 /PRNewswire/ -- Qasim Nawab has joined Suffolk Construction's West Coast office as Director of Preconstruction Services. A senior construction professional, Nawab brings 30 years plus experience as an estimator, over 20 of those in Southern California where he has earned a reputation for excellence. "Qasim has a strong track record among clients and sub-contractors for the quality and integrity of his work," says Dave...

2009-03-09 07:00:00

BASKING RIDGE, N.J., March 9 /PRNewswire-FirstCall/ -- Hooper Holmes (Amex: HH) today announced that it will release fourth quarter and year end 2008 financial results before market on Friday, March 13, 2009. The Company will host a conference call on Friday, March 13, 2009 at 11:00am Eastern Time. Conference Call To participate in the conference call, please dial 888-790-3758 or 210-839-8398, pass code: Hooper Holmes. A live web cast will be hosted on the Company's web site located at...

2008-12-16 17:45:00

VANCOUVER, Dec. 16 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) today announced that Robert Pilz, Chief Financial Officer and Vice President Finance, has left the Company. Livleen Kaler, Director, Finance and Administration will assume the duties of Mr. Pilz, effective today. About Response Biomedical Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP(R) Platform for clinical and environmental...

2008-10-23 09:00:28

Research and Markets (http://www.researchandmarkets.com/research/765597/chemicals_manageme) has announced the addition of the "Chemicals Management After REACH: A Business Guide" report to their offering. We are getting excellent feedback on this report, a revised 2008 edition of which is now available. It has an update on the REACH Implementation Projects and improved hyperlinks for further information in a complimentary electronic version available to customers as soon as they place...